Minerva Neurosciences annual free cash flow
2013
2014
2017
2022
Minerva Neurosciences Free Cash Flow (FCF) History (NERV)
Minerva Neurosciences reported −$24.7M in free cash flow for fiscal 2022, a decrease of $27.7M from the previous fiscal year.
View full Minerva Neurosciences company overviewMinerva Neurosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$24.7M | −$27.7M | — | — |
| 2017 | 2017-12-31 | $3.0M | $39.0M | — | — |
| 2014 | 2014-12-31 | −$36.0M | −$33.8M | — | — |
| 2013 | 2013-12-31 | −$2.2M | — | — | — |
Minerva Neurosciences quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Minerva Neurosciences free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Minerva Neurosciences filings at SEC.gov ↗